BPC-157 is a synthetic peptide derived from a naturally occurring protein found in human gastric juice. BPC stands for Body Protection Compound, and the peptide consists of 15 amino acids — a sequence that does not occur freely in nature but is derived from a larger protective protein found in the stomach. It was first isolated and studied in the context of gastrointestinal research, where it demonstrated a strong ability to protect and repair stomach and intestinal tissue. Since then, its research applications have expanded significantly into musculoskeletal, neurological, and vascular biology.
BPC-157 in Research: What It Is, What It Does, and How It's Used
BPC-157 · Published March 28, 2026 · Updated April 28, 2026 · 8 min read
Quick Answer
BPC-157 is a 15-amino-acid pentadecapeptide derived from a gastric protective protein, used in preclinical research to study tissue repair, angiogenesis, neuroprotection, and inflammation. Studies span tendon, ligament, muscle, gut, and organ injury models with biomarker and histological endpoints. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
Frequently Asked Questions
What is BPC-157 in research contexts?
+
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid pentadecapeptide derived from a protective sequence found in human gastric juice. It is studied in preclinical rodent models for its effects on tissue repair, vascular signaling, and cytoprotection.
What are the most studied research applications of BPC-157?
+
BPC-157 is most studied in gastrointestinal repair, tendon and ligament injury, muscle repair, angiogenesis, and cytoprotection across multiple organ systems in rodent models. The literature spans more than 100 published preclinical studies.
How is BPC-157 typically administered in research models?
+
Subcutaneous and intramuscular injection are the most common research routes, with oral administration used in gut barrier and gastrointestinal studies due to BPC-157's stability in gastric juice.
Is BPC-157 approved for human use?
+
No. BPC-157 is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.
Glossary
Key terms used in this article.
- Pentadecapeptide
- A peptide chain composed of 15 amino acid residues linked by peptide bonds.
- Cytoprotection
- The biological process by which cells are protected from injury caused by chemical, ischemic, or oxidative insults.
- Angiogenesis
- The formation of new blood vessels from pre-existing vasculature, central to tissue repair.
- VEGF
- Vascular Endothelial Growth Factor, a signaling glycoprotein that stimulates new blood vessel formation.
- Nitric Oxide (NO)
- A short-lived gaseous signaling molecule that triggers vasodilation and supports endothelial function.
- Preclinical Model
- A laboratory or animal study conducted before human research, used to investigate mechanism, safety, and efficacy.
- Subcutaneous Injection
- Administration of a compound into the layer of fat beneath the skin, a common route for peptide research.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
